Biotech in Belgium: news and updates

News and Trends 25 Aug 2022

KU Leuven spin-off AstriVax raises €30M for vaccine platform – first stop, yellow fever

A Belgian university spinoff has generated the biggest seed capital financing in the institution’s history. Closing with €30 million ($30 million), AstriVax will draw on technology developed at the KU…

August 25, 2022 - 3 minutesmins - By Jim Cornall

Optics11 Life receives €5 million in funding for drug development

News and Trends 24 Aug 2022

Millions in funding and new board members for Belgian mRNA company

The mRNA technologies company eTheRNA has raised €39 million ($38.7 million) in series B2 financing. Belgium-based eTheRNA will use the money to expand investment in its integrated mRNA technology platform…

August 24, 2022 - 3 minutesmins - By Liza Laws

News and Trends 5 Aug 2022

Beyond Biotech podcast 8: Biotech Growth Trust, Deep Science Ventures, Endogena Therapeutics, eureKARE

This week’s podcast guests are Laura Fletcher, head of business development and strategic partnerships at Deep Science Ventures; Matthias Steger, CEO of Endogena Therapeutics; Rodolphe Besserve, CEO, and Georges Rawadi,…

August 5, 2022 - 3 minutesmins - By Jim Cornall

In Depth 3 Aug 2022

The biggest European biotech investments in July 2022

The mRNA firm Normax Biomed snagged Europe’s biggest private biotech investment in July 2022, with runners-up including AgomAb and Tropic Biosciences. Life sciences manufacturing companies saw a big windfall in…

August 3, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 1 Aug 2022

Clinical hold on trial for colorectal cancer drug lifted by FDA

A clinical hold has been lifted by the US Food and Drug Administration (FDA) on a trial for a treatment for colorectal cancer after changes were made by the company…

August 1, 2022 - 2 minutesmins - By Liza Laws

News and Trends 19 Jul 2022

eureKARE launches synthetic biology studio network

eureKARE, a company focused on financing and building next generation biotech companies in the fields of synthetic biology, has launched its first synthetic biology studio in Belgium. In conjunction with…

July 19, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 14 Jul 2022

Agomab bags $114 million in thriving regenerative medicine sector

The Belgian company Agomab Therapeutics has topped up its Series B round by $40.5 million to hit $114 million. This Pfizer-led financing round extension is just the latest sign that…

July 14, 2022 - 3 minutesmins - By Victor Kotsev

News and Trends 28 Jun 2022

MRM Health starts pouchitis clinical trial

MRM Health, a Belgian clinical-stage biopharmaceutical company, has received regulatory approval from the Federal Agency for Medicines and Health Products (FAMHP) in Belgium to start a phase 2 trial with…

June 28, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 22 Jun 2022

Galapagos to acquire CellPoint and AboundBio to advance cell therapies

Belgian headquartered biotech Galapagos NV has acquired CellPoint and AboundBio, a move the Belgian company said propels it into next-generation cell therapy. Galapagos said the acquisitions give it access to…

June 22, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 21 Jun 2022

Biotalys and Novozymes partner on biofungicide

Belgian agtech company Biotalys and Danish biotech company Novozymes have entered into a partnership to expand opportunities for Evoca, Biotalys’ first proprietary biocontrol product. Novozymes will explore additional routes for…

June 21, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 21 Jun 2022

New agreement could lead to first African-owned COVID-19 vaccine

A year after the creation of the mRNA Vaccine Technology Transfer Hub, two biotech companies – Afrigen Biologics and the Univercells Group – are set to work together. The agreement…

June 21, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 16 Jun 2022

Gimv creates new fund for life science companies

European investment company Gimv has launched its fifth investment platform with a focus on venture capital investments in innovative life sciences companies. Gimv said after growth in its existing healthcare…

June 16, 2022 - 2 minutesmins - By Jim Cornall

radiopharmaceutical treatments precirix jeito

News and Trends 17 Mar 2022

€80M Series B Establishes European Champion in Radiopharmaceuticals

Big European venture capital firms Jeito, Forbion, and Inkef Capital have teamed up to propel the local radiopharmaceutical scene by investing €80M in the Belgian firm Precirix. Europe has a…

March 17, 2022 - 4 minutesmins - By Jonathan Smith

Belgium biotech vc fund newton biocapital japan

News and Trends 18 Feb 2022

Belgian VC Fund Leads Investment Wave in Japanese Biotech

As US and European investor interest in Japanese biopharma startups spikes, the Belgian venture capital firm Newton Biocapital has launched a €150M fund to harness synergy between European and Japanese…

February 18, 2022 - 4 minutesmins - By Jonathan Smith

argenx efgartigimod treatment autoimmune disease myasthenia gravis

News and Trends 21 Dec 2021

Argenx’s Potential Blockbuster Gets FDA Nod for Autoimmune Disease

US regulators have approved the first-in-class drug efgartigimod for the treatment of the rare muscle disease generalized myasthenia gravis, opening up its developer argenx to billion-dollar revenues. Efgartigimod, to be…

December 21, 2021 - 4 minutesmins - By Anita Chakraverty

News and Trends 30 Jun 2021

GSK Raises Eyebrows in Checkpoint Inhibitor Megadeal with iTeos

Analysts are abuzz over GSK’s co-development deal with immuno-oncology specialist iTeos Therapeutics earlier this month, wondering if it overpaid for the Belgian company’s next-generation checkpoint inhibitor. GSK’s oncology deal with…

June 30, 2021 - 5 minutesmins - By Victor Kotsev

Ziphius Vaccines Covid 19 pandemic vaccine treatment

News and Trends 1 Jun 2021

Next-Generation mRNA Vaccine Technology Unveiled in Series A Round

Messenger RNA vaccines have been at the forefront of the global struggle against the Covid-19 pandemic over the past year. Now scientists are working to upgrade the technology: enter the…

June 1, 2021 - 4 minutesmins - By Victor Kotsev

Best in Biotech 25 Jan 2021

The 15 Best Biotech Companies in Belgium

Meet the most successful biotech companies in Belgium, a small country that makes a huge contribution to the biotech industry. With over 140 operating biotech companies and a solid network…

January 25, 2021 - 8 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 30 Jul 2020

Llama-Derived Nanobodies Join the Fight Against Covid-19

Newly-launched Belgian startup ExeVir Bio will develop ‘nanobodies’ that bind very precisely to key areas of the Covid-19 virus and other coronaviruses after raking in €23M in Series A. Based…

July 30, 2020 - 3 minutesmins - By Victor Kotsev

microfluidics lab on a chip miDiagnostics

Startup Scout 1 May 2020

Belgian Company Harnesses Lab-on-a-Chip Technology to Diagnose Disease

The Belgian startup miDiagnostics is developing technology to diagnose diseases quickly, accurately, and at the point-of-care using a silicon lab-on-a-chip and nanoscale-precision microfluidics. Having good diagnostics in place can save…

May 1, 2020 - 4 minutesmins - By Jonathan Smith

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering